Search

Author/Creator Wolf, Douglas C

2. Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned. Issue 1 (19th December 2017)

Authors:
Afzali, Anita; Ciorba, Matthew A; Schwartz, David A; Sharaf, Mai; Fourment, Chris; Ritter, Timothy; Wolf, Douglas C; Shafran, Ira; Randall, Charles W; Kane, Sunanda V
Journal:
Inflammatory bowel diseases
Issue:
Volume 24:Issue 1(2018)
Page Start:
2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned. Issue 1 (1st January 2018)

Authors:
Afzali, Anita; Ciorba, Matthew A; Schwartz, David A; Sharaf, Mai; Fourment, Chris; Ritter, Timothy; Wolf, Douglas C; Shafran, Ira; Randall, Charles W; Kane, Sunanda V
Journal:
Inflammatory bowel diseases
Issue:
Volume 24:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials. (25th April 2018)

Authors:
Panaccione, Remo; Sandborn, William J; D'Haens, Geert; Wolf, Douglas C; Berg, Sofie; Maa, Jen-fue; Petersson, Joel; Robinson, Anne M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 8(2018:Aug.)
Page Start:
930
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies. Issue 10383 (8th April 2023)

Authors:
Sandborn, William J; Vermeire, Séverine; Peyrin-Biroulet, Laurent; Dubinsky, Marla C; Panes, Julian; Yarur, Andres; Ritter, Timothy; Baert, Filip; Schreiber, Stefan; Sloan, Sheldon; Cataldi, Fabio; Shan, Kevin; Rabbat, Christopher J; Chiorean, Michael; Wolf, Douglas C; Sands, Bruce E; D'Haens, Ge...
Journal:
Lancet
Issue:
Volume 401:Issue 10383(2023)
Page Start:
1159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Implementing a globally harmonized risk assessment‐based approach for regulatory decision‐making of crop protection products. Issue 10 (4th March 2020)

Authors:
Wolf, Douglas C; Aggarwal, Manoj; Battalora, Michael; Blacker, Ann; Catalano, Shadia I; Cazarin, Karen; Lautenschalaeger, Daniele; Pais, Mariana C; Rodríguez, Mauricio; Rupprecht, Kent; Serex, Tessa L; Mehta, Jyotigna
Journal:
Pest management science
Issue:
Volume 76:Issue 10(2020)
Page Start:
3311
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study. (13th January 2021)

Authors:
Sandborn, William J; Feagan, Brian G; Hanauer, Stephen; Vermeire, Severine; Ghosh, Subrata; Liu, Wenzhong J; Petersen, AnnKatrin; Charles, Lorna; Huang, Vivian; Usiskin, Keith; Wolf, Douglas C; D'Haens, Geert
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15:Number 7(2021)
Page Start:
1120
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study. (September 2020)

Authors:
Feagan, Brian G; Sandborn, William J; Danese, Silvio; Wolf, Douglas C; Liu, Wenzhong J; Hua, Steven Y; Minton, Neil; Olson, Allan; D'Haens, Geert
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 5:Number 9(2020)
Page Start:
819
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis. Issue 6 (25th October 2018)

Authors:
Feagan, Brian G; Schreiber, Stefan; Wolf, Douglas C; Axler, Jeffrey L; Kaviya, Arpeat; James, Alexandra; Curtis, Rebecca I; Geransar, Parnia; Stallmach, Andreas; Ehehalt, Robert; Bokemeyer, Bernd; Khalid, Javaria Mona; O'Byrne, Sharon
Journal:
Inflammatory bowel diseases
Issue:
Volume 25:Issue 6(2019)
Page Start:
1028
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗